Statistics for Annovis Bio (id:10145 ANVS)
Valuation metrics
Market cap
96.17M
Enterprise value
89.60M
Trailing P/E (ttm)
-1.07
Forward P/E
-3.85
PEG ratio
-3.85
Price/Sales (ttm)
Price/Book (mrq)
13.10
Enterprise Value/Revenue
Enterprise Value/EBITDA
-2.70
Overview
Shares outstanding
13.05M
Float
10.82M
Shares short
1.40M
% Held by insiders
0.20%
% Held by institutions
0.08%
Average volume (10 days)
247.59K
Average volume (90 days)
Price summary
52-Week low
4.53
52-Week high
22.49
52-Week change
-11.13%
Beta
50-Day moving average
8.47
200-Day moving average
8.99
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-154.58%
Return on equity
-596.70%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-40,939,112.00
Diluted EPS (ttm)
-4.22
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
12.64M
Total cash per share (mrq)
0.92
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
266.40%
Book value per share (mrq)
0.53
Cash flow
Cash flow statement
-22,974,234.00
Levered free cash flow (LFCF)
-11,572,214.00